Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • belco_mc belco_mc Aug 30, 2012 8:58 AM Flag

    Eteplirsen = $2 billion +

    If exon 51 is 15% of the DMD population in the US alone and can generate $500 million in revenues, then it's reasonable that adding a few more eons will generate in excess of $2 billion in the US alone.

    SRPT market cap is still only $300 million. Easy triple from here as we gain more evidence that the drug works.

 
SRPT
13.57+0.50(+3.83%)Mar 27 4:00 PMEDT